 | • レポートコード：MRC308GR11487 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の非オピオイドパッチの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の非オピオイドパッチ市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 非オピオイドパッチの成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
非オピオイドパッチ市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・医療用医薬品、一般用医薬品
用途別セグメント
・病院薬局、ドラッグストア、オンライン薬局
主要な市場プレーヤー
・NEXGEL Advanced Hydrogel Solutions、Viatris Inc.、Johnson and Johnson、Teva Pharmaceutical Industries Ltd、Sorrento Therapeutics Inc.、Hisamitsu Pharmaceutical Co.,Inc.、Endo International plc.、Purdue Pharma L.P.、Amneal Pharmaceuticals LLC、Grunenthal
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、非オピオイドパッチ製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な非オピオイドパッチメーカーの企業概要、2019年～2022年までの非オピオイドパッチの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な非オピオイドパッチメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別非オピオイドパッチの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの非オピオイドパッチの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での非オピオイドパッチ市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および非オピオイドパッチの産業チェーンを掲載しています。
・第14、15章では、非オピオイドパッチの販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 非オピオイドパッチの概要
– 種類別分析（2018年vs2022年vs2029年）：医療用医薬品、一般用医薬品
– 用途別分析（2018年vs2022年vs2029年）：病院薬局、ドラッグストア、オンライン薬局
– 世界の非オピオイドパッチ市場規模・予測
– 世界の非オピオイドパッチ生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– NEXGEL Advanced Hydrogel Solutions、Viatris Inc.、Johnson and Johnson、Teva Pharmaceutical Industries Ltd、Sorrento Therapeutics Inc.、Hisamitsu Pharmaceutical Co.,Inc.、Endo International plc.、Purdue Pharma L.P.、Amneal Pharmaceuticals LLC、Grunenthal
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：医療用医薬品、一般用医薬品
・用途別分析2018年-2029年：病院薬局、ドラッグストア、オンライン薬局
・非オピオイドパッチの北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・非オピオイドパッチのヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・非オピオイドパッチのアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・非オピオイドパッチの南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・非オピオイドパッチの中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Non-Opioid Patch
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Non-Opioid Patch Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Prescription Medicines
1.3.3 OTC Medicines
1.4 Market Analysis by Application
1.4.1 Overview: Global Non-Opioid Patch Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Drug Stores
1.4.4 Online Pharmacies
1.5 Global Non-Opioid Patch Market Size & Forecast
1.5.1 Global Non-Opioid Patch Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Non-Opioid Patch Sales Quantity (2018-2029)
1.5.3 Global Non-Opioid Patch Average Price (2018-2029)
2 Manufacturers Profiles
2.1 NEXGEL Advanced Hydrogel Solutions
2.1.1 NEXGEL Advanced Hydrogel Solutions Details
2.1.2 NEXGEL Advanced Hydrogel Solutions Major Business
2.1.3 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product and Services
2.1.4 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 NEXGEL Advanced Hydrogel Solutions Recent Developments/Updates
2.2 Viatris Inc.
2.2.1 Viatris Inc. Details
2.2.2 Viatris Inc. Major Business
2.2.3 Viatris Inc. Non-Opioid Patch Product and Services
2.2.4 Viatris Inc. Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Viatris Inc. Recent Developments/Updates
2.3 Johnson and Johnson
2.3.1 Johnson and Johnson Details
2.3.2 Johnson and Johnson Major Business
2.3.3 Johnson and Johnson Non-Opioid Patch Product and Services
2.3.4 Johnson and Johnson Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Johnson and Johnson Recent Developments/Updates
2.4 Teva Pharmaceutical Industries Ltd
2.4.1 Teva Pharmaceutical Industries Ltd Details
2.4.2 Teva Pharmaceutical Industries Ltd Major Business
2.4.3 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product and Services
2.4.4 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
2.5 Sorrento Therapeutics Inc.
2.5.1 Sorrento Therapeutics Inc. Details
2.5.2 Sorrento Therapeutics Inc. Major Business
2.5.3 Sorrento Therapeutics Inc. Non-Opioid Patch Product and Services
2.5.4 Sorrento Therapeutics Inc. Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sorrento Therapeutics Inc. Recent Developments/Updates
2.6 Hisamitsu Pharmaceutical Co.,Inc.
2.6.1 Hisamitsu Pharmaceutical Co.,Inc. Details
2.6.2 Hisamitsu Pharmaceutical Co.,Inc. Major Business
2.6.3 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product and Services
2.6.4 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hisamitsu Pharmaceutical Co.,Inc. Recent Developments/Updates
2.7 Endo International plc.
2.7.1 Endo International plc. Details
2.7.2 Endo International plc. Major Business
2.7.3 Endo International plc. Non-Opioid Patch Product and Services
2.7.4 Endo International plc. Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Endo International plc. Recent Developments/Updates
2.8 Purdue Pharma L.P.
2.8.1 Purdue Pharma L.P. Details
2.8.2 Purdue Pharma L.P. Major Business
2.8.3 Purdue Pharma L.P. Non-Opioid Patch Product and Services
2.8.4 Purdue Pharma L.P. Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Purdue Pharma L.P. Recent Developments/Updates
2.9 Amneal Pharmaceuticals LLC
2.9.1 Amneal Pharmaceuticals LLC Details
2.9.2 Amneal Pharmaceuticals LLC Major Business
2.9.3 Amneal Pharmaceuticals LLC Non-Opioid Patch Product and Services
2.9.4 Amneal Pharmaceuticals LLC Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Amneal Pharmaceuticals LLC Recent Developments/Updates
2.10 Grunenthal
2.10.1 Grunenthal Details
2.10.2 Grunenthal Major Business
2.10.3 Grunenthal Non-Opioid Patch Product and Services
2.10.4 Grunenthal Non-Opioid Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Grunenthal Recent Developments/Updates
3 Competitive Environment: Non-Opioid Patch by Manufacturer
3.1 Global Non-Opioid Patch Sales Quantity by Manufacturer (2018-2023)
3.2 Global Non-Opioid Patch Revenue by Manufacturer (2018-2023)
3.3 Global Non-Opioid Patch Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Non-Opioid Patch by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Non-Opioid Patch Manufacturer Market Share in 2022
3.4.2 Top 6 Non-Opioid Patch Manufacturer Market Share in 2022
3.5 Non-Opioid Patch Market: Overall Company Footprint Analysis
3.5.1 Non-Opioid Patch Market: Region Footprint
3.5.2 Non-Opioid Patch Market: Company Product Type Footprint
3.5.3 Non-Opioid Patch Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Non-Opioid Patch Market Size by Region
4.1.1 Global Non-Opioid Patch Sales Quantity by Region (2018-2029)
4.1.2 Global Non-Opioid Patch Consumption Value by Region (2018-2029)
4.1.3 Global Non-Opioid Patch Average Price by Region (2018-2029)
4.2 North America Non-Opioid Patch Consumption Value (2018-2029)
4.3 Europe Non-Opioid Patch Consumption Value (2018-2029)
4.4 Asia-Pacific Non-Opioid Patch Consumption Value (2018-2029)
4.5 South America Non-Opioid Patch Consumption Value (2018-2029)
4.6 Middle East and Africa Non-Opioid Patch Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Non-Opioid Patch Sales Quantity by Type (2018-2029)
5.2 Global Non-Opioid Patch Consumption Value by Type (2018-2029)
5.3 Global Non-Opioid Patch Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Non-Opioid Patch Sales Quantity by Application (2018-2029)
6.2 Global Non-Opioid Patch Consumption Value by Application (2018-2029)
6.3 Global Non-Opioid Patch Average Price by Application (2018-2029)
7 North America
7.1 North America Non-Opioid Patch Sales Quantity by Type (2018-2029)
7.2 North America Non-Opioid Patch Sales Quantity by Application (2018-2029)
7.3 North America Non-Opioid Patch Market Size by Country
7.3.1 North America Non-Opioid Patch Sales Quantity by Country (2018-2029)
7.3.2 North America Non-Opioid Patch Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Non-Opioid Patch Sales Quantity by Type (2018-2029)
8.2 Europe Non-Opioid Patch Sales Quantity by Application (2018-2029)
8.3 Europe Non-Opioid Patch Market Size by Country
8.3.1 Europe Non-Opioid Patch Sales Quantity by Country (2018-2029)
8.3.2 Europe Non-Opioid Patch Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Non-Opioid Patch Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Non-Opioid Patch Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Non-Opioid Patch Market Size by Region
9.3.1 Asia-Pacific Non-Opioid Patch Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Non-Opioid Patch Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Non-Opioid Patch Sales Quantity by Type (2018-2029)
10.2 South America Non-Opioid Patch Sales Quantity by Application (2018-2029)
10.3 South America Non-Opioid Patch Market Size by Country
10.3.1 South America Non-Opioid Patch Sales Quantity by Country (2018-2029)
10.3.2 South America Non-Opioid Patch Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Non-Opioid Patch Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Non-Opioid Patch Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Non-Opioid Patch Market Size by Country
11.3.1 Middle East & Africa Non-Opioid Patch Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Non-Opioid Patch Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Non-Opioid Patch Market Drivers
12.2 Non-Opioid Patch Market Restraints
12.3 Non-Opioid Patch Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Non-Opioid Patch and Key Manufacturers
13.2 Manufacturing Costs Percentage of Non-Opioid Patch
13.3 Non-Opioid Patch Production Process
13.4 Non-Opioid Patch Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Non-Opioid Patch Typical Distributors
14.3 Non-Opioid Patch Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Non-Opioid Patch Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-Opioid Patch Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. NEXGEL Advanced Hydrogel Solutions Basic Information, Manufacturing Base and Competitors
Table 4. NEXGEL Advanced Hydrogel Solutions Major Business
Table 5. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product and Services
Table 6. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. NEXGEL Advanced Hydrogel Solutions Recent Developments/Updates
Table 8. Viatris Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Viatris Inc. Major Business
Table 10. Viatris Inc. Non-Opioid Patch Product and Services
Table 11. Viatris Inc. Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Viatris Inc. Recent Developments/Updates
Table 13. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 14. Johnson and Johnson Major Business
Table 15. Johnson and Johnson Non-Opioid Patch Product and Services
Table 16. Johnson and Johnson Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Johnson and Johnson Recent Developments/Updates
Table 18. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 19. Teva Pharmaceutical Industries Ltd Major Business
Table 20. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product and Services
Table 21. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 23. Sorrento Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Sorrento Therapeutics Inc. Major Business
Table 25. Sorrento Therapeutics Inc. Non-Opioid Patch Product and Services
Table 26. Sorrento Therapeutics Inc. Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Sorrento Therapeutics Inc. Recent Developments/Updates
Table 28. Hisamitsu Pharmaceutical Co.,Inc. Basic Information, Manufacturing Base and Competitors
Table 29. Hisamitsu Pharmaceutical Co.,Inc. Major Business
Table 30. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product and Services
Table 31. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Hisamitsu Pharmaceutical Co.,Inc. Recent Developments/Updates
Table 33. Endo International plc. Basic Information, Manufacturing Base and Competitors
Table 34. Endo International plc. Major Business
Table 35. Endo International plc. Non-Opioid Patch Product and Services
Table 36. Endo International plc. Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Endo International plc. Recent Developments/Updates
Table 38. Purdue Pharma L.P. Basic Information, Manufacturing Base and Competitors
Table 39. Purdue Pharma L.P. Major Business
Table 40. Purdue Pharma L.P. Non-Opioid Patch Product and Services
Table 41. Purdue Pharma L.P. Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Purdue Pharma L.P. Recent Developments/Updates
Table 43. Amneal Pharmaceuticals LLC Basic Information, Manufacturing Base and Competitors
Table 44. Amneal Pharmaceuticals LLC Major Business
Table 45. Amneal Pharmaceuticals LLC Non-Opioid Patch Product and Services
Table 46. Amneal Pharmaceuticals LLC Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Amneal Pharmaceuticals LLC Recent Developments/Updates
Table 48. Grunenthal Basic Information, Manufacturing Base and Competitors
Table 49. Grunenthal Major Business
Table 50. Grunenthal Non-Opioid Patch Product and Services
Table 51. Grunenthal Non-Opioid Patch Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Grunenthal Recent Developments/Updates
Table 53. Global Non-Opioid Patch Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Non-Opioid Patch Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Non-Opioid Patch Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Non-Opioid Patch, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Non-Opioid Patch Production Site of Key Manufacturer
Table 58. Non-Opioid Patch Market: Company Product Type Footprint
Table 59. Non-Opioid Patch Market: Company Product Application Footprint
Table 60. Non-Opioid Patch New Market Entrants and Barriers to Market Entry
Table 61. Non-Opioid Patch Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Non-Opioid Patch Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Non-Opioid Patch Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Non-Opioid Patch Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Non-Opioid Patch Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Non-Opioid Patch Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Non-Opioid Patch Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Non-Opioid Patch Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Non-Opioid Patch Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Non-Opioid Patch Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Non-Opioid Patch Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Non-Opioid Patch Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Non-Opioid Patch Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Non-Opioid Patch Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Non-Opioid Patch Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Non-Opioid Patch Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Non-Opioid Patch Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Non-Opioid Patch Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Non-Opioid Patch Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Non-Opioid Patch Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Non-Opioid Patch Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Non-Opioid Patch Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Non-Opioid Patch Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Non-Opioid Patch Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Non-Opioid Patch Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Non-Opioid Patch Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Non-Opioid Patch Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Non-Opioid Patch Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Non-Opioid Patch Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Non-Opioid Patch Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Non-Opioid Patch Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Non-Opioid Patch Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Non-Opioid Patch Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Non-Opioid Patch Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Non-Opioid Patch Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Non-Opioid Patch Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Non-Opioid Patch Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Non-Opioid Patch Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Non-Opioid Patch Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Non-Opioid Patch Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Non-Opioid Patch Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Non-Opioid Patch Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Non-Opioid Patch Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Non-Opioid Patch Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Non-Opioid Patch Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Non-Opioid Patch Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Non-Opioid Patch Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Non-Opioid Patch Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Non-Opioid Patch Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Non-Opioid Patch Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Non-Opioid Patch Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Non-Opioid Patch Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Non-Opioid Patch Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Non-Opioid Patch Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Non-Opioid Patch Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Non-Opioid Patch Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Non-Opioid Patch Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Non-Opioid Patch Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Non-Opioid Patch Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Non-Opioid Patch Raw Material
Table 121. Key Manufacturers of Non-Opioid Patch Raw Materials
Table 122. Non-Opioid Patch Typical Distributors
Table 123. Non-Opioid Patch Typical Customers
List of Figures
Figure 1. Non-Opioid Patch Picture
Figure 2. Global Non-Opioid Patch Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-Opioid Patch Consumption Value Market Share by Type in 2022
Figure 4. Prescription Medicines Examples
Figure 5. OTC Medicines Examples
Figure 6. Global Non-Opioid Patch Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Non-Opioid Patch Consumption Value Market Share by Application in 2022
Figure 8. Hospital Pharmacies Examples
Figure 9. Drug Stores Examples
Figure 10. Online Pharmacies Examples
Figure 11. Global Non-Opioid Patch Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Non-Opioid Patch Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Non-Opioid Patch Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Non-Opioid Patch Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Non-Opioid Patch Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Non-Opioid Patch Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Non-Opioid Patch by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Non-Opioid Patch Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Non-Opioid Patch Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Non-Opioid Patch Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Non-Opioid Patch Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Non-Opioid Patch Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Non-Opioid Patch Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Non-Opioid Patch Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Non-Opioid Patch Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Non-Opioid Patch Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Non-Opioid Patch Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Non-Opioid Patch Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Non-Opioid Patch Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Non-Opioid Patch Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Non-Opioid Patch Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Non-Opioid Patch Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Non-Opioid Patch Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Non-Opioid Patch Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Non-Opioid Patch Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Non-Opioid Patch Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Non-Opioid Patch Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Non-Opioid Patch Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Non-Opioid Patch Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Non-Opioid Patch Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Non-Opioid Patch Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Non-Opioid Patch Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Non-Opioid Patch Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Non-Opioid Patch Consumption Value Market Share by Region (2018-2029)
Figure 53. China Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Non-Opioid Patch Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Non-Opioid Patch Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Non-Opioid Patch Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Non-Opioid Patch Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Non-Opioid Patch Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Non-Opioid Patch Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Non-Opioid Patch Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Non-Opioid Patch Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Non-Opioid Patch Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Non-Opioid Patch Market Drivers
Figure 74. Non-Opioid Patch Market Restraints
Figure 75. Non-Opioid Patch Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Non-Opioid Patch in 2022
Figure 78. Manufacturing Process Analysis of Non-Opioid Patch
Figure 79. Non-Opioid Patch Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source